Respiratory News and Research

RSS

New treatment improves immune function in 13-year-old with Wiskott-Aldrich syndrome

In a novel approach that works around the gene defect in Wiskott-Aldrich syndrome, an inherited immune deficiency disorder, researchers used an alternative cell signaling pathway to significantly improve immune function in a 13-year-old boy with the disease.

15 Apr 2011

Study finds difference in intensive care services in the U.K. and U.S.

Patients who receive intensive care services are very different in the United States than in the United Kingdom, according to a new study that compared admission and mortality statistics from ICUs in each country.

15 Apr 2011

Sirolimus may help treat lymphangioleiomyomatosis in women

An Oregon Health & Science University researcher has co-authored an international study that revealed a drug approved to prevent rejection in organ transplant patients helped treat a rare lung disease in women.

12 Apr 2011

Study quantifies health effects of Delhi's environmental interventions

Recent radical changes in air quality regulations in Delhi, India, have had a substantial positive effect on the health of city residents, according to new research co-authored by Andrew Foster, professor of economics and community health and an associate at Brown's Population Studies and Training Center.

12 Apr 2011

Viral infection likely to encourage pneumonia spread

Bacteria that cause pneumonia and meningitis are only able to spread when individuals are infected with flu, says a scientist reporting at the Society for General Microbiology's Spring Conference in Harrogate. The work could have implications for the management of influenza pandemics and could help reduce incidence of pneumococcal infections in very young children, who are more susceptible to disease.

11 Apr 2011

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment

Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.

11 Apr 2011

Positive link between 100% fruit juice intake and reduced risk of chronic diseases

Drinking 100 percent fruit juices could have protective health benefits similar to those of whole fruits, according to research presented in a literature review yesterday at the 2011 Experimental Biology meeting.

11 Apr 2011

New study finds no significant benefit of bosentan against IPF

A new study has demonstrated no significant benefit of taking the drug bosentan for idiopathic pulmonary fibrosis.

11 Apr 2011

Air pollution on freeways may lead to brain damage: Study

Earlier research has shown that air pollution from cars and trucks on Southern California freeways – that contains soot, pavement dust and other toxic substances - can cause respiratory disease, heart attacks, cancer and premature death. Now a new study has shown that exposure to pollution particles roughly one-thousandth the width of a human hair may lead to brain damage in mice, including signs associated with memory loss and Alzheimer’s disease. The study comes from University of Southern California and is published in the journal Environmental Health Perspectives.

10 Apr 2011

Survivors of severe critical illness requiring intensive care do not regain physical or psychological health

A unique and richly detailed long-term study of survivors of severe critical illness requiring intensive care found that even those who were previously healthy, young and working did not regain the physical or psychological health they had before their illness.

8 Apr 2011

Canadian political parties called upon to focus on health system during election campaign

The Health Action Lobby today called on all political parties to focus on the health system during the federal election campaign. HEAL is a coalition of 35 national health organizations that represents a broad cross-section of health providers, health regions, institutions & facilities.

8 Apr 2011

Quest Diagnostics Simplexa molecular test receives bronze award for best new product

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa™ molecular test on the 3M™ Integrated Cycler was honored with a bronze award for best new science and medical diagnostic product during the 2011 Edison Awards gala ceremony last night in New York City.

From Quest Diagnostics 7 Apr 2011

Progesterone gel can reduce preterm birth in women with short cervix

A groundbreaking clinical study of a new method for preventing premature birth in millions of women each year, published in the medical journal Ultrasound in Obstetrics & Gynecology, shows that the rate of early preterm delivery in women can be reduced by 45 percent - simply by treating pregnant women at risk with a low-cost gel of natural progesterone during the midtrimester of pregnancy until term.

7 Apr 2011

Progesterone benefits women with short cervix, finds NIH study

A National Institutes of Health study has found that progesterone, a naturally occurring hormone, reduced the rate of preterm birth before the 33rd week of pregnancy by 45 percent among one category of at risk women.

7 Apr 2011

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced results from the MAGELLAN Phase 3 trial evaluating the investigational oral anticoagulant rivaroxaban for the prevention of venous thromboembolism in hospitalized patients with acute medical illnesses.

6 Apr 2011

Novartis' TOBI Podhaler receives Health Canada NOC for Pa treatment in CF patients

Novartis Canada announced today that it has received Health Canada Notice of Compliance for TOBI Podhaler, a fast and convenient inhaled therapy for cystic fibrosis patients aged six and over.

6 Apr 2011

Post-infection treatment with NanoViricides FluCide reduces lung lesions caused by lethal influenza infection

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide™ drug candidates resulted in dramatic reduction in the number of lung lesions that are caused by a lethal influenza virus infection. These findings were seen in the most recent H1N1 influenza animal study.

5 Apr 2011

Adherence to HHS Physical Activity Guidelines can reduce mortality risk

Following federal government recommendations on exercise might lead to a longer life for all adults, according to a new study of nearly 250,000 Americans.

5 Apr 2011

Inserm Transfert, MedImmune collaborate to advance medical science research

MedImmune, the global biologics business of AstraZeneca, and Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research, today announced a three-year strategic collaboration to advance research across a range of therapeutic areas including oncology, respiratory, inflammation, and autoimmune diseases.

5 Apr 2011

First period before age of 10 linked to lower lung capacity later in life

"Adult women who had their first menstruation at the age of 10 or earlier have significantly lower lung capacity than women who had their first period at 13", Ferenc Macsali, lead author of the study and a researcher at the Haukeland Hospital in Bergen (Norway), tells SINC.

4 Apr 2011

Respiratory News and Research

New treatment improves immune function in 13-year-old with Wiskott-Aldrich syndrome

Study finds difference in intensive care services in the U.K. and U.S.

Sirolimus may help treat lymphangioleiomyomatosis in women

Study quantifies health effects of Delhi's environmental interventions

Viral infection likely to encourage pneumonia spread

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment

Positive link between 100% fruit juice intake and reduced risk of chronic diseases

New study finds no significant benefit of bosentan against IPF

Air pollution on freeways may lead to brain damage: Study

Survivors of severe critical illness requiring intensive care do not regain physical or psychological health

Canadian political parties called upon to focus on health system during election campaign

Quest Diagnostics Simplexa molecular test receives bronze award for best new product

Progesterone gel can reduce preterm birth in women with short cervix

Progesterone benefits women with short cervix, finds NIH study

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

Novartis' TOBI Podhaler receives Health Canada NOC for Pa treatment in CF patients

Post-infection treatment with NanoViricides FluCide reduces lung lesions caused by lethal influenza infection

Adherence to HHS Physical Activity Guidelines can reduce mortality risk

Inserm Transfert, MedImmune collaborate to advance medical science research

First period before age of 10 linked to lower lung capacity later in life

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News